The research for cancer treatment is moving forward at a rapid pace. With over 12.5 million new cases of cancer being identified worldwide each year, improved diagnosis and treatment is essential, yet oncology clinical research remains complex, demanding and is continually evolving.
At PCI, we understand that each project is unique and continual internal and external pressures mean traditional approaches to drug development are difficult to sustain. Increasingly, pharmaceutical companies are relying on partnership outsourcing to achieve their goals.
Applying industry leading solutions and best practices, we partner with clients to optimize patient studies by utilizing advanced technology solutions and innovative supply chain models to ensure optimal drug delivery. Underpinned by innovation and quality, we support the delivery of next generation oncology therapies with peace of mind.